Gene expression during osteoclast-like cell formation induced by antifusion regulatory protein-1/CD98/4F2 monoclonal antibodies (MAbs): c-src is selectively induced by anti-FRP-1 MAb

Bone

Volumn 25, Issue 1, 1999, Pages 17-24

  Higuchi, Y ^a   Ito, M ^a   Tajima, M ^a   Higuchi, S ^a   Miyamoto, N ^a   Nishio, M ^a   Kawano, M ^a   Kusagawa, S ^a   Tsurudome, M ^a   Sudo, A ^a   Katou, K ^a   Uchida, A ^a   Ito, Y ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

c src; CD98; FRP 1; Monocytes; Osteoclasts; Receptor activator of NF B ligand (RANKL)

Indexed keywords

ACID PHOSPHATASE; ADENOSINE TRIPHOSPHATASE; BIOLOGICAL MARKER; CALCITONIN RECEPTOR; CARBONATE DEHYDRATASE; CATHEPSIN K; CELL RECEPTOR; GALECTIN 3; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MESSENGER RNA; MONOCLONAL ANTIBODY; OSTEOPONTIN; REGULATOR PROTEIN; TARTARIC ACID; VITRONECTIN RECEPTOR;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; ONCOGENE C FOS; ONCOGENE SRC; OSTEOCLAST; PROTEIN INDUCTION; STATISTICAL ANALYSIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD98; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENES, SRC; HUMANS; IMMUNOHISTOCHEMISTRY; MONOCYTES; OSTEOCLASTS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032991034     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00103-9     Document Type: Article

References (26)

1. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest. 90:1992;1622-1627.
2. Burger K.N., Verkleij A.J. Membrane fusion. Experientia. 46:1990;631-644.
3. Chirgwin D.W., Przybyla A.E., MacDonald R.J., Rutter W.J. , Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry. 18:1979;5294-5299.
4. Dong S., Hughes R.C. Macrophage surface glycoproteins binding to galectin-3. Glycoconjugate J. 14:1997;267-274.
5. Hashimoto Y., Masuko T., Yagita H., Endho N., Kanazawa J., Tazawa J. A proliferation-associated rat cell surface antigen recognized by a murine monoclonal antibody. Gann. 74:1983;819-821.
6. Haynes B.F., Hemler M.E., Mann D.L., et al. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol. 126:1981;1409-1414.
7. Hemler M.E., Strominger J.L. Characterization of the antigen recognized by the monoclonal antibody (4F2) Different molecular forms on human T and B lymphoblastoid cell lines . J Immunol. 131:1982;334-340.
8. Higuchi S., Tabata N., Tajima M., et al. Induction of human osteoclast-like cells by treatment of blood monocytes with anti-fusion regulatory protein-1/CD98 monoclonal antibodies. J Bone Miner Res. 13:1998;44-49.
9. c-src in association with intracellular membranes. J Cell Biol. 119:1992;1003-1013.
10. Ito Y., Komada S., Kusagawa M., et al. Fusion regulation proteins on the cell surface Isolation and characterization of monoclonal antibodies which enhance giant polykaryocyte formation in Newcastle disease virus-infected cell lines of human origin . J Virol. 66:1992;5999-6007.
11. Johnson R.S., Spiegelman B.M., Papaiannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 71:1992;577-586.
12. Lacey D.L., Timms E., Tan H.-L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
13. Matsuzaki K., Udagawa N., Takahashi N., et al. Osteoclast differentiation factor induced osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun. 246:1998;199-204.
14. Ohgimoto S., Tabata N., Suga S., et al. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. J Immunol. 135:1995;3585-3592.
15. Ohta H., Tsurudome M., Matsumura H., et al. Molecular and biologic characterization of fusion regulatory proteins Anti-FRP mAbs induced HIV-mediated cell fusion via an integrin system . Eur Mol Biol Org J. 13:1994;2044-2055.
16. Quackenbush E., Clabby M., Gottesdiener K.M., et al. Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen A type II membrane glycoprotein involved in normal and neoplastic cell growth . Proc Natl Acad Sci USA. 84:1987;6526-6530.
17. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:1991;693-702.
18. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocrine Rev. 13:1992;66-80.
19. Tabata N., Ido M., Suga S., et al. Protein tyrosine kinase activation provides an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal antibody induced cell fusion mediated by HIV gp160. Med Microbiol Immunol. 186:1997;115-123.
20. Tabata N., Ito M., Shimokata K., et al. Expression of Fusion regulatory proteins (FRPs) on human peripheral blood monocyte. J Immunol. 153:1995;3256-3266.
21. 2 terminus. J Biol Chem. 20:1987;9574-9580.
22. Udagawa N., Takahashi N., Akatsu T., et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1989;1805-1813.
23. Udagawa N., Takahashi N., Akatsu T., et al. Origin of osteoclasts Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells . Proc Natl Acad Sci USA. 87:1990;7260-7264.
24. Wang Z.Q., Ovitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:1992;741-745.
25. White J.M. Viral and cellular membrane fusion proteins. Annu Rev Physiol. 52:1990;675-697.
26. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.